Evalution of prophylactic effect and complication of Tranexamic Acid on blood loss during and after Elective Caesarean Section

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181021041403N1

Enrollment

100

Registered

2018-12-29

Start date

2019-01-05

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bleeding during and after delivery of cesarean section. Delivery by elective caesarean section

Interventions

Intervention 1: Intervention group: In this group, patients who are candidates for cesarean section are given10 mg/kg tranexamic acid before surgery and Drug effects and complications are reviewed 6 w

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: All pregnant women who are candidates for elective cesarean section

Exclusion criteria

Exclusion criteria: High body mass index History of venous thrombosis Uterine myoma Liver and kidney disease History of high birth weight Plasenta previa,acreta and... Pre eclampsia Disseminated Intravascular Coagulation

Design outcomes

Primary

Measure	Time frame
Hb value. Timepoint: Hemoglobin measurement before surgery and six hours after surgery. Method of measurement: laboratory kit.;Number of used gases. Timepoint: Counting the gases used during the surgery. Method of measurement: Gas count.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNazanin Shahraki Ghadimi

Islamic Azad University

n.sh.ghadimi@iauzah.ac.ir+98 54 3328 8322

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026